Home Blog of Signal Transduction PI3K/Akt/mTOR PI3K The inhibition of AKT pathway by truncated CNT-1 enhances cell apoptosis

Category

Archives

Popular Post

ESKM, a novel therapeutic agent for sensitive and resistant PH+ leukemias

The mechanism of resistance to JAK2 inhibitor in myeloproliferative neoplasms patients

Effects of PARP inhibitors in BRCA gene-mutated ovarian cancer

DASATINIB; An inhibitor of Receptor Tyrosine Kinase

GP130/JAK/STAT3 signaling pathway induces multiple myeloma

The inhibition of AKT pathway by truncated CNT-1 enhances cell apoptosis

 

The phosphoinositide 3-kinase (PI3K)-AKT signaling pathway is crucial for promoting mammal cell growth, survival and proliferation. However, it reduces cell apoptosis and causes cancer. Nakagawa et al. demonstrated a new negative regulator of AKT signaling, truncated CNT-1 (tCNT-1), can promote cell apoptosis and suppress cell growth and proliferation. The article was published on Nature Structural & Molecular Biology.

 

The cell-suicide program is activated by caspases, a cysteine-aspartic proteases that cleave multiple substrates to mediate cell apoptosis. The Caenorhabditis elegans cell death protein, CED-3, is a caspase that is essential for cell death-execution process in C. elegans. Researchers found CNT-1 can be cut by CED-3 and produces tCNT-1, an N-terminal cleavage product. This product had strong phosphoinositide (PI)-binding affinity, therefore, it outcompeted AKT for binding to PIP3, inhibited PI3K-AKT pathway for enhancing cell apoptosis. By further investigation, researchers tested whether tCNT-1 can influence other functions of AKT kinases and PI3K, such as reducing life span and stress resistance in C. elegans. However, the absence of cnt-1 gene did not influence the two processes, which indicates tCNT-1 suppresses PI3K-AKT pathway in an apoptosis-specific manner.

 

Reference:
Nat Struct Mol Biol. 2014 Nov 10;10.1038/nsmb.2915.

Related Products

Cat.No. Product Name Information
S1078 MK-2206 2HCl MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM in cell-free assays, respectively; no inhibitory activities against 250 other protein kinases observed. MK-2206 2HCl induces autophagy and apoptosis in cancer cells. Phase 2.
S8019 Capivasertib (AZD5363) Capivasertib (AZD5363) potently inhibits all isoforms of Akt(Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM in cell-free assays, similar to P70S6K/PKA and lower activity towards ROCK1/2. Phase 2.

Related Targets

PI3K Akt